Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001854270-25-000065
Filing Date
2025-05-06
Accepted
2025-05-06 16:48:53
Documents
80
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q snti-20250331.htm   iXBRL 10-Q 1455463
2 EX-10.1 q125ex101_consultingagreem.htm EX-10.1 8867
3 EX-31.1 q12510-qex311_ceo.htm EX-31.1 11227
4 EX-31.2 q12510-qex312_cfo.htm EX-31.2 11199
5 EX-32.1 q12510-qex321_ceo.htm EX-32.1 5588
6 EX-32.2 q12510-qex322_cfo.htm EX-32.2 5579
  Complete submission text file 0001854270-25-000065.txt   6736043

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT snti-20250331.xsd EX-101.SCH 51731
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT snti-20250331_cal.xml EX-101.CAL 63779
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT snti-20250331_def.xml EX-101.DEF 270066
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT snti-20250331_lab.xml EX-101.LAB 590013
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT snti-20250331_pre.xml EX-101.PRE 436466
83 EXTRACTED XBRL INSTANCE DOCUMENT snti-20250331_htm.xml XML 688758
Mailing Address 2 CORPORATE DRIVE, FIRST FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 2 CORPORATE DRIVE, FIRST FLOOR SOUTH SAN FRANCISCO CA 94080 (650) 382-3281
Senti Biosciences, Inc. (Filer) CIK: 0001854270 (see all company filings)

EIN.: 862437900 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40440 | Film No.: 25918008
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)